ALPMY
Astellas Pharma, Inc.After hours14.35−0.03 −0.21%USD
OTC Markets OTCPK · as of Oct 14, 15:59 ET · 15m delay
Open
14.32
Prev close
14.38
Day range
14.2514.37
52-week range
10.0517.35
Volume
17.70K0.14×
Mkt cap
25.73B
P/E ttm
10.87
Fwd P/E
31.89
EPS ttm
1.32
Div yield
3.44%
Earnings
Nov 4, 2026
From 52w high
−17.29%
ALPMY earnings and estimates
ALPMY Next Report
Yahoo Finance · Nasdaq
Report date
Wed, Nov 4
Before the open
EPS consensus
$—
EPS growth vs year ago
—
Revenue consensus
$594.09B
+13.3% vs year ago
Options-implied move
—
no expiry soon after the report
Past 0 reactions
—
EPS: Actual vs Estimate
No reported quarters.
Price Reaction
close before → close after the report
No reported quarters.
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | — | — | — | $594.09B | +13.3% | — — | — — | 0 / 0 |
| Next quarter Dec 2026 | — | — | — | $616.88B | +8.0% | — — | — — | 0 / 0 |
| Current year Mar 2027 | 1.23 | — | +20.2% | $2.37T | +166.4% | 1.31 −6.4% | 1.31 −6.4% | 0 / 1 |
| Next year Mar 2028 | 1.14 | — | −7.5% | $2.20T | −6.9% | 1.17 −3.0% | 1.17 −3.0% | 0 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.